15 February 2017 - Huvepharma® is investing EUR 150 million in a plant extension at its facility in Peshtera, Bulgaria. The extended facility will offer more than 3,000m3 of additional fermentation capacity and will double the site's production capabilities.
9 February 2017 - Feed enzymes have gained in strategic importance for Huvepharma over the past few years and have now become the most significant product group for the company.
The goal of the company is to combine tradition and innovative spirit with focus on complete partnership with all customers. The modernization of the manufacturing plant in the town of Peshtera and the current needs of the administration necessitates the erection of a new corporative building complying with the requirements for contemporary office environment with inspiring modern vision reflecting the high-technology and innovative spirit of the company.
Vetmulin® 0 Days Withdrawal Period
This year the congress was held over 5 days in Dublin with more than 2 700 participants presented.
Huvepharma® at IPVS & ESPHM 2016: Stand C4